210 related articles for article (PubMed ID: 24058548)
1. Autoantibodies to estrogen receptor α in systemic sclerosis (SSc) as pathogenetic determinants and markers of progression.
Giovannetti A; Maselli A; Colasanti T; Rosato E; Salsano F; Pisarri S; Mezzaroma I; Malorni W; Ortona E; Pierdominici M
PLoS One; 2013; 8(9):e74332. PubMed ID: 24058548
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to estrogen receptor α interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus.
Colasanti T; Maselli A; Conti F; Sanchez M; Alessandri C; Barbati C; Vacirca D; Tinari A; Chiarotti F; Giovannetti A; Franconi F; Valesini G; Malorni W; Pierdominici M; Ortona E
Arthritis Rheum; 2012 Mar; 64(3):778-87. PubMed ID: 21968947
[TBL] [Abstract][Full Text] [Related]
3. Increased Frequency of Activated Switched Memory B Cells and Its Association With the Presence of Pulmonary Fibrosis in Diffuse Cutaneous Systemic Sclerosis Patients.
Simon D; Balogh P; Erdő-Bonyár S; Böröcz K; Minier T; Czirják L; Berki T
Front Immunol; 2021; 12():686483. PubMed ID: 34276673
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody-mediated regulation of B cell responses by functional anti-CD22 autoantibodies in patients with systemic sclerosis.
Odaka M; Hasegawa M; Hamaguchi Y; Ishiura N; Kumada S; Matsushita T; Komura K; Sato S; Takehara K; Fujimoto M
Clin Exp Immunol; 2010 Feb; 159(2):176-84. PubMed ID: 19919568
[TBL] [Abstract][Full Text] [Related]
5. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
[TBL] [Abstract][Full Text] [Related]
6. Early systemic sclerosis: marker autoantibodies and videocapillaroscopy patterns are each associated with distinct clinical, functional and cellular activation markers.
Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A
Arthritis Res Ther; 2013; 15(3):R63. PubMed ID: 23718566
[TBL] [Abstract][Full Text] [Related]
7. Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis.
Fertig N; Domsic RT; Rodriguez-Reyna T; Kuwana M; Lucas M; Medsger TA; Feghali-Bostwick CA
Arthritis Rheum; 2009 Jul; 61(7):958-65. PubMed ID: 19565553
[TBL] [Abstract][Full Text] [Related]
8. Assessment of T regulatory cells and expanded profiling of autoantibodies may offer novel biomarkers for the clinical management of systemic sclerosis and undifferentiated connective tissue disease.
Cordiali-Fei P; Mussi A; D'Agosto G; Trento E; Bordignon V; Trincone S; Vento A; Sperduti I; Cristaudo A; Ensoli F
Clin Dev Immunol; 2013; 2013():390563. PubMed ID: 23818915
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor gene polymorphisms in Japanese patients with systemic sclerosis.
Hoshi M; Yasuoka H; Kuwana M
Clin Exp Rheumatol; 2008; 26(5):914-7. PubMed ID: 19032828
[TBL] [Abstract][Full Text] [Related]
11. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage.
Ogawa F; Shimizu K; Hara T; Muroi E; Komura K; Takenaka M; Hasegawa M; Fujimoto M; Takehara K; Sato S
Arch Dermatol Res; 2010 Jan; 302(1):27-35. PubMed ID: 19844733
[TBL] [Abstract][Full Text] [Related]
13. Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity.
Matsushita T; Hamaguchi Y; Hasegawa M; Takehara K; Fujimoto M
Rheumatology (Oxford); 2016 Feb; 55(2):263-7. PubMed ID: 26350483
[TBL] [Abstract][Full Text] [Related]
14. Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis.
Kim D; Peck A; Santer D; Patole P; Schwartz SM; Molitor JA; Arnett FC; Elkon KB
Arthritis Rheum; 2008 Jul; 58(7):2163-73. PubMed ID: 18576347
[TBL] [Abstract][Full Text] [Related]
15. Increased frequency of class I and II anti-human leukocyte antigen antibodies in systemic lupus erythematosus and scleroderma and associated factors: a comparative study.
Tozkir H; Pamuk ON; Duymaz J; Gurkan H; Yazar M; Sari G; Tanrikulu H; Pamuk GE
Int J Rheum Dis; 2016 Dec; 19(12):1304-1309. PubMed ID: 25292400
[TBL] [Abstract][Full Text] [Related]
16. Low expression of estrogen receptor β in T lymphocytes and high serum levels of anti-estrogen receptor α antibodies impact disease activity in female patients with systemic lupus erythematosus.
Maselli A; Conti F; Alessandri C; Colasanti T; Barbati C; Vomero M; Ciarlo L; Patrizio M; Spinelli FR; Ortona E; Valesini G; Pierdominici M
Biol Sex Differ; 2016; 7():3. PubMed ID: 26759713
[TBL] [Abstract][Full Text] [Related]
17. Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations.
Gourh P; Arnett FC; Assassi S; Tan FK; Huang M; Diekman L; Mayes MD; Reveille JD; Agarwal SK
Arthritis Res Ther; 2009; 11(5):R147. PubMed ID: 19799786
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
[TBL] [Abstract][Full Text] [Related]
19. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity.
Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A
Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1520-7. PubMed ID: 24515450
[TBL] [Abstract][Full Text] [Related]
20. Anti-CXCL4 Antibody Reactivity Is Present in Systemic Sclerosis (SSc) and Correlates with the SSc Type I Interferon Signature.
Lande R; Mennella A; Palazzo R; Pietraforte I; Stefanantoni K; Iannace N; Butera A; Boirivant M; Pica R; Conrad C; Chizzolini C; Riccieri V; Frasca L
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
